Trials / Terminated
TerminatedNCT01353690
Autologous Cell Therapy for Ischemic Heart Failure
A Prospective, Multicenter, Feasibility Study of Autologous Muscle-derived Cell (AMDC) Transplantation for Treatment of Advanced Ischemic Heart Failure
- Status
- Terminated
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 9 (actual)
- Sponsor
- Cook MyoSite · Industry
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this clinical study is to investigate the safety and feasibility of Autologous Muscle-derived Cells (AMDC; a preparation of a patient's own cells) as a treatment for patients with advanced heart failure caused by ischemia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | AMDC | Cell Treatment |
Timeline
- Start date
- 2011-02-05
- Primary completion
- 2012-12-12
- Completion
- 2014-06-01
- First posted
- 2011-05-16
- Last updated
- 2021-07-01
Locations
2 sites across 1 country: Canada
Source: ClinicalTrials.gov record NCT01353690. Inclusion in this directory is not an endorsement.